Pharvaris to Participate in H.C. Wainwright 1st Annual

ZUG, Switzerland, July 14, 2022 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin-B2-receptor...

Related Keywords

Switzerland ,Maryann Cimino , ,Annual Hereditary Angioedema ,Nasdaq Phvs ,Pharvarisnv ,